Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 23

Cited In for PubMed (Select 17510378)

1.

Gene methylation profiles as prognostic markers in ovarian clear cell and endometrioid adenocarcinomas.

Chen CA, Chiang YC, Chang MC, Hu YH, You SL, Cheng YY, Chou CY, Cheng WF.

Am J Transl Res. 2015 Jan 15;7(1):139-52. eCollection 2015.

2.

DNA methylation and microRNA biomarkers for noninvasive detection of gastric and colorectal cancer.

Toiyama Y, Okugawa Y, Goel A.

Biochem Biophys Res Commun. 2014 Dec 5;455(1-2):43-57. doi: 10.1016/j.bbrc.2014.08.001. Epub 2014 Aug 13. Review.

PMID:
25128828
3.

Global and gene-specific DNA methylation pattern discriminates cholecystitis from gallbladder cancer patients in Chile.

Kagohara LT, Schussel JL, Subbannayya T, Sahasrabuddhe N, Lebron C, Brait M, Maldonado L, Valle BL, Pirini F, Jahuira M, Lopez J, Letelier P, Brebi-Mieville P, Ili C, Pandey A, Chatterjee A, Sidransky D, Guerrero-Preston R.

Future Oncol. 2015 Jan;11(2):233-49. doi: 10.2217/fon.14.165. Epub 2014 Jul 28.

4.

The predictive but not prognostic value of MGMT promoter methylation status in elderly glioblastoma patients: a meta-analysis.

Yin AA, Zhang LH, Cheng JX, Dong Y, Liu BL, Han N, Zhang X.

PLoS One. 2014 Jan 13;9(1):e85102. doi: 10.1371/journal.pone.0085102. eCollection 2014.

5.

Expression and methylation of mitochondrial transcription factor a in chronic obstructive pulmonary disease patients with lung cancer.

Peng H, Yang M, Chen ZY, Chen P, Guan CX, Xiang XD, Cai S, Chen Y, Fang X.

PLoS One. 2013 Dec 18;8(12):e82739. doi: 10.1371/journal.pone.0082739. eCollection 2013.

6.

Promoter hypomethylation of EpCAM-regulated bone morphogenetic protein gene family in recurrent endometrial cancer.

Hsu YT, Gu F, Huang YW, Liu J, Ruan J, Huang RL, Wang CM, Chen CL, Jadhav RR, Lai HC, Mutch DG, Goodfellow PJ, Thompson IM, Kirma NB, Huang TH.

Clin Cancer Res. 2013 Nov 15;19(22):6272-85. doi: 10.1158/1078-0432.CCR-13-1734. Epub 2013 Sep 27.

7.

Methylated DNA and microRNA in Body Fluids as Biomarkers for Cancer Detection.

Ma Y, Wang X, Jin H.

Int J Mol Sci. 2013 May 16;14(5):10307-31. doi: 10.3390/ijms140510307.

8.

NotI microarrays: novel epigenetic markers for early detection and prognosis of high grade serous ovarian cancer.

Kashuba V, Dmitriev AA, Krasnov GS, Pavlova T, Ignatjev I, Gordiyuk VV, Gerashchenko AV, Braga EA, Yenamandra SP, Lerman M, Senchenko VN, Zabarovsky E.

Int J Mol Sci. 2012 Oct 18;13(10):13352-77. doi: 10.3390/ijms131013352.

9.

DNA methylation in peripheral blood: a potential biomarker for cancer molecular epidemiology.

Li L, Choi JY, Lee KM, Sung H, Park SK, Oze I, Pan KF, You WC, Chen YX, Fang JY, Matsuo K, Kim WH, Yuasa Y, Kang D.

J Epidemiol. 2012;22(5):384-94. Epub 2012 Aug 4. Review.

10.

Promoter methylation of tumor suppressor genes in esophageal squamous cell carcinoma.

Li JS, Ying JM, Wang XW, Wang ZH, Tao Q, Li LL.

Chin J Cancer. 2013 Jan;32(1):3-11. doi: 10.5732/cjc.011.10381. Epub 2012 May 8. Review.

11.

Why do results conflict regarding the prognostic value of the methylation status in colon cancers? The role of the preservation method.

Tournier B, Chapusot C, Courcet E, Martin L, Lepage C, Faivre J, Piard F.

BMC Cancer. 2012 Jan 13;12:12. doi: 10.1186/1471-2407-12-12.

12.

Epigenetics of kidney cancer and bladder cancer.

Hoffman AM, Cairns P.

Epigenomics. 2011 Feb;3(1):19-34. doi: 10.2217/epi.10.64. Review.

13.

Assays for hypermethylation of the BRCA1 gene promoter in tumor cells to predict sensitivity to PARP-inhibitor therapy.

Ibragimova I, Cairns P.

Methods Mol Biol. 2011;780:277-91. doi: 10.1007/978-1-61779-270-0_17.

14.

NID2 and HOXA9 promoter hypermethylation as biomarkers for prevention and early detection in oral cavity squamous cell carcinoma tissues and saliva.

Guerrero-Preston R, Soudry E, Acero J, Orera M, Moreno-López L, Macía-Colón G, Jaffe A, Berdasco M, Ili-Gangas C, Brebi-Mieville P, Fu Y, Engstrom C, Irizarry RA, Esteller M, Westra W, Koch W, Califano J, Sidransky D.

Cancer Prev Res (Phila). 2011 Jul;4(7):1061-72. doi: 10.1158/1940-6207.CAPR-11-0006. Epub 2011 May 10.

16.

Methods in DNA methylation profiling.

Zuo T, Tycko B, Liu TM, Lin JJ, Huang TH.

Epigenomics. 2009 Dec;1(2):331-45. doi: 10.2217/epi.09.31. Review.

17.

Molecular detection of B-cell neoplasms by specific DNA methylation biomarkers.

Wang MX, Wang HY, Zhao X, Srilatha N, Zheng D, Shi H, Ning J, Duff DJ, Taylor KH, Gruner BA, Caldwell CW.

Int J Clin Exp Pathol. 2010 Jan 28;3(3):265-79.

18.

Serum DNA can define tumor-specific genetic and epigenetic markers in gliomas of various grades.

Lavon I, Refael M, Zelikovitch B, Shalom E, Siegal T.

Neuro Oncol. 2010 Feb;12(2):173-80. doi: 10.1093/neuonc/nop041. Epub 2010 Feb 1.

19.
20.

Promoter methylation and the detection of breast cancer.

Brooks J, Cairns P, Zeleniuch-Jacquotte A.

Cancer Causes Control. 2009 Nov;20(9):1539-50. doi: 10.1007/s10552-009-9415-y. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk